We’ve just launched a new portal to help you explore stocks, crypto, ETFs, and more data

REGN

551.42 USD
9.51
1.70%
Last update May 8, 3:44 PM EDT
Main market
Day range
521.04
551.51
Previous close
560.92999
Open
547.01
Access this stock data via API
Subscribe
Regeneron Pharmaceuticals, Inc.
551.42
9.51
1.70%

Financials

Income statement

Fiscal date 2024 2023 2022 2021
Total reported revenue 14.2B 13.1B 12.2B 16.1B
Cost of revenue 2.0B 1.8B 1.6B 2.4B
Gross profit 12.2B 11.3B 10.6B 13.6B
Operating expense
Research & development 5.2B 4.4B 3.6B 2.9B
Selling general and admin 3.0B 2.6B 2.1B 1.8B
Other operating expenses 53.4M -2.1M -89.9M -45.6M
Operating income 4.0B 4.2B 5.0B 9.0B
Non operating interest income
Income 711.4M 495.9M 160.1M 45.8M
Expense 55.2M 73M 59.4M 57.3M
Other income expense 133M -456.8M -235.9M 342.5M
Pretax income 4.8B 4.2B 4.9B 9.3B
Tax provision 367.3M 245.7M 520.4M 1.3B
Net income 4.4B 4.0B 4.3B 8.1B
Basic EPS 40.9 37.1 40.5 76.4
Diluted EPS 38.3 34.8 38.2 72.0
Basic average shares 107.9M 106.7M 107.1M 105.7M
Diluted average shares 107.9M 106.7M 107.1M 105.7M
EBITDA 5.2B 5.1B 5.5B 9.3B
Net income from continuing op. 4.4B 4.0B 4.3B 8.1B
Minority interests
Preferred stock dividends
Main market

Exchange is currently active.
Closing in 13 minutes

15:46
00:00
09:30
16:00
23:59

Trading Hours (Monday - Friday):

Pre-market
04:00 - 09:30
Main market
09:30 - 16:00
Post-market
16:00 - 20:00
All times are displayed in the America/New_York timezone (EDT, UTC-04:00).